Thousands in the Lehigh Valley struggle with depression every day, but thanks to the TMS Center of the Lehigh Valley, they are not alone in their fight. We are the region’s first transcranial magnetic stimulation (TMS) treatment facility and one of the most experienced centers on the east coast, having performed over ten thousand TMS treatments.
TMS therapy is an FDA approved, non-drug, non-invasive depression treatment for patients suffering from depression who are not satisfied with the results of standard anti-depressant medications and psychotherapy.
Our dedicated staff is made up of tireless advocates who, with our expertise and compassion, help people struggling with depression conquer their disease and get their smiles back.
See real client testimonials and gain insight on how people respond and feel after going through our TMS therapy program. Our reviews are overwhelmingly positive!
TMS Therapy is now covered by all major insurance companies including Medicare, Highmark Blue Shield, Capital BlueCross Blue Shield, United Healthcare, and Aetna.
Dr. Paul Gross is a board-certified psychiatrist who has spent over four decades at the forefront of mental health care. A graduate of the University of Pennsylvania School of Medicine, Dr Gross is certified in Adult, Geriatric, and Forensic Psychiatry. His career has been defined by a commitment to innovation, clinical excellence, and compassionate care.
Dr. Gross is the founder of the TMS Center of the Lehigh Valley, established in 2011. He was the first physician to introduce Transcranial Magnetic Stimulation (TMS) Therapy to the Lehigh Valley, and since then, he has performed over two thousand patients, helping individuals find relief from depression and other treatment-resistant conditions. Under his leadership, the TMS Center of the Lehigh Valley has grown into one of the most respected TMS facilities on the East Coast.
In addition to his TMS work, Dr. Gross is the founder of the Lehigh Center for clinical research, established in 2010, where he continues to lead clinical trials focused on advancing psychiatric treatment. He also maintains a private psychiatric practice and is an active member of the Clinical TMS Society.
With his commitment to advancing mental health treatment through research, innovation, and compassionate care, he has become a respected member of the region’s psychiatric community.
